The University Medical Center Groningen, formerly Groningen University Hospital, is the main hospital in Groningen, Netherlands. The medical centre is affiliated with the University of Groningen and offers supraregional tertiary care to the northern part of the Netherlands.

During the past decade, Department of Pulmonary diseases conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Pulmonary diseases" are "COPD" (1 trials), "Central Sleep Apnea" (1 trials), "Cheyne-Stokes Respiration" (1 trials), "Dyspnea" (1 trials) and "Mechanical Ventilation Complication" (1 trials). Many other conditions were trialed in "Department of Pulmonary diseases" in a lesser frequency.

Most popular intervention types in "Department of Pulmonary diseases" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Monitoring physiology with Electrical Impedance Tomography, Electromyography and transcutaneous carbon dioxide measurements." (1 trials) and "Nasal high flow oxygen therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Pulmonary diseases" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department of Pulmonary diseases". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Department of Pulmonary diseases, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Pulmonary diseases, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".